Jones, R. L., Chawla, N. S., Attia, S., Pollack, S., Cranmer, L. D., Lopez-Pousa, A., Seetharam, M., Burgess, M. A., Chmielowski, B., Siontis, B. L., Trent, J. C., Wilky, B. A., Bui, N., Chugh, R., Somaiah, N., Tine, B. A. V., Chawla, S. P. (2025). A randomized phase III trial of catequentinib hydrochloride (AL3818) versus placebo in subjects with metastatic or advanced leiomyosarcoma (LMS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11506